Company Number: 14062873

Analysis Date: 2025-07-19 11:53 UTC

Financial Health Assessment of JUNO STRATEGIC LTD (as of 31 March 2024)

---

1. Financial Health Score: D

Explanation:
The company exhibits concerning signs of financial distress with negative net current assets and shareholders' funds, indicating a balance sheet "illness." While it is still active and filing on time, the negative working capital and equity position suggest the company is in a weak financial state, needing swift remedial action.

---

2. Key Vital Signs:

Vital Sign	Value (£)	Interpretation
Share Capital	21	Minimal capital base, typical for a small private company.
Current Assets	5,208	Includes cash and debtors; low but positive.
Cash at Bank	3,198	Limited cash reserves; a vital lifeline for daily operations.
Debtors	2,010	Receivables indicating some income expected but possibly slow collection.
Current Liabilities	8,066	Debts due within one year exceed assets — a red flag for liquidity.
Net Current Assets (Working Capital)	-2,858	Negative value indicates inability to cover short-term debts with current assets.
Shareholders’ Funds (Equity)	-2,878	Negative equity means liabilities exceed assets; company is technically insolvent.

---

3. Diagnosis:

JUNO STRATEGIC LTD is showing clear "symptoms of financial distress." The negative net current assets and shareholders' funds point to a balance sheet imbalance: the company owes more in the short term than it owns in liquid and receivable assets. This situation can be likened to a patient whose vital signs show a weakened heart (capital base) and poor blood circulation (cash flow), unable to meet immediate obligations.

The company has a very small capital injection (£21) and relies heavily on director advances (£2,010), which suggests external funding pressures. The increase from positive equity in 2023 (£20) to negative equity in 2024 (-£2,878) indicates losses or unpaid liabilities accumulated in the year.

The company is still active, compliant with filing deadlines, and has no overdue returns, demonstrating operational diligence. However, the financial "symptoms" warrant immediate attention to avoid escalation to insolvency.

---

4. Recommendations:

1. Improve Liquidity:

   • Secure additional cash injections or short-term financing to cover current liabilities and restore positive working capital.
   • Accelerate debtor collections to convert receivables into cash faster.

2. Cost Management:

   • Review and reduce operating expenses to stem losses and preserve cash reserves.
   • Avoid further director loans unless formalised and repayable to prevent future complications.

3. Capital Restructuring:

   • Consider increasing share capital or attracting new investment to improve the equity base and "strengthen the heart" of the company.
   • Explore restructuring liabilities, possibly negotiating extended payment terms with creditors.

4. Financial Monitoring:

   • Implement regular cash flow forecasting and financial health checks to detect early warning signs.
   • Engage a financial adviser or insolvency practitioner for expert guidance on turnaround strategies.

5. Strategic Review:

   • Evaluate business model and revenue streams to ensure sustainability and growth potential.
   • Consider diversification or new contracts to improve income.

---